← all drugs
Methylphenidate Hydrochloride Tablet, Extended Release
in shortage · Psychiatry · Snapshot: 2026-10-09
Day 1,171
of this shortage, counting from the FDA's first posting on 07/26/2023
- Manufacturers listed
- Trigen Laboratories, LLC, Vertical Pharmaceuticals, LLC, Janssen Pharmaceuticals, Teva Pharmaceuticals USA, Inc., Sun Pharmaceutical Industries, Inc., Lannett Company, Inc.
- Reported reason(s)
- Demand increase for the drug; Other; Discontinuation of the manufacture of the drug
- Machine-readable
- JSON for this drug
Presentations (34)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01) | Janssen Pharmaceuticals | Available | 09/17/2026 |
| Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01) | Janssen Pharmaceuticals | Available | 09/17/2026 |
| Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | 09/18/2026 |
| Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | 09/18/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37) | Lannett Company, Inc. | Unavailable | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01) | Teva Pharmaceuticals USA, Inc. | Available | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37) | Lannett Company, Inc. | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | 09/18/2026 |
| Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37) | Lannett Company, Inc. | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01) | Teva Pharmaceuticals USA, Inc. | Available | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | 09/18/2026 |
| Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01) | Janssen Pharmaceuticals | Available | 09/17/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Vertical Pharmaceuticals, LLC | Available | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) | Trigen Laboratories, LLC | Limited Availability | 10/01/2026 |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37) | Lannett Company, Inc. | Unavailable | 10/01/2026 |
| Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01) | Janssen Pharmaceuticals | Available | 09/17/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-10-03 — Methylphenidate Hydrochloride Tablet, Extended Release: availability wording revised for 2 presentation(s)
- 2026-09-17 — Methylphenidate Hydrochloride Tablet, Extended Release: availability wording revised for 2 presentation(s)
- 2026-09-03 — Methylphenidate Hydrochloride Tablet, Extended Release: availability wording revised for 1 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.